02.11.2017 20:11:00

Teva Pharmaceutical Industries Ltd -- Moody's says Teva's US generics business will face increased price pressure in 2018; a credit negative

Announcement: Moody's says Teva's US generics business will face increased price pressure in 2018; a credit negative

Vollständigen Artikel bei Moodys lesen